Can inhalations of hyaluronidase be used in acute respiratory distress-syndrome in patients with COVID-19?
Hyaluronidase is currently not included into Russian or foreign guidelines on the treatment of acute respiratory distress-syndrome in patients with COVID-19, and such treatment is not supported by evidence of clinical effectiveness. Hyaluronidase can only be used for COVID-19 within clinical trials.
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Russo |
| Pubblicazione: |
Izdatelstvo OKI
2020-10-01
|
| Serie: | Качественная клиническая практика |
| Soggetti: | |
| Accesso online: | https://www.clinvest.ru/jour/article/view/522 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|